The Latest Cardiac and Vascular News
Fred Lampropoulos will continue to serve as Chairman of Merit’s Board of Directors Merit announces preliminary unaudited revenue for the quarter ended June 30, 2025 SOUTH JORDAN, Utah, July 07, 2025 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today the appointment […]
BOSTON–(BUSINESS WIRE)–Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive patient-specific therapeutic decisions, has named Dr. Robert “Bob” Pelberg as its new senior vice president of medical affairs. A highly accomplished cardiologist and nationally recognized expert in cardiovascular computed tomography […]
Medtronic advances pipeline with update on multi-organ denervation study and additional data recently presented at EuroPCR 2025 Medtronic, a global leader in healthcare technology, today announced that it has treated the first patient in its SPYRAL GEMINI Pilot program (including ‘OFF MED’ and ‘ON MED’ studies).* The first patient […]
LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced that it will report financial results for the fourth quarter and fiscal year 2025 […]
BAAR, Switzerland–(BUSINESS WIRE)–CorFlow Therapeutics AG (CorFlow), a pioneering company in the field of cardiac care targeting microvascular disease, today announced that the U.S. Food & Drug Administration (FDA) has approved the company’s technology for investigational device exemption (IDE), which allows the pivotal clinical trial to begin at U.S. hospitals. CorFlow will now […]
SANTA MONICA, Calif., July 7, 2025 /PRNewswire/ — Lifeforce, the world’s largest longevity medicine platform, and Toku, a health technology company using AI to translate a single retinal image into real-time biological age and cardiovascular risk scores, have announced a nationwide…
TOKYO, July 7, 2025 /PRNewswire/ — Simplex Quantum, an AI-driven healthcare technology company, is proud to announce that Dr. Marco Perez, Associate Professor of Medicine at Stanford University and a renowned expert in cardiac electrophysiology, has agreed to act as an advisor to Simplex…
COPENHAGEN, Denmark, July 7, 2025 /PRNewswire/ — CathVision ApS, a medical technology company developing electrophysiology solutions for cardiac ablation, announces the market release of ECGenius™ System Version 3.4, introducing multiple software enhancements aimed at improving…
Funding, which will support clinical studies of Restore’s novel transcatheter device, was co-led by Pitango HealthTech and a global strategic partner, with continued investment from existing investors including Peregrine Ventures, another global strategic partner, and new investment from…
Expanded indication makes SIR-Spheres® the first and only radioembolization therapy in the U.S. approved to treat both unresectable hepatocellular carcinoma and metastatic colorectal cancer WOBURN, Mass., July 7, 2025 /PRNewswire/ — Sirtex Medical (“Sirtex”), a leading manufacturer of…
